CIBC Bancorp USA’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
CIBC Bancorp USA's SANA Position: Q3 2026 in Review
CIBC Bancorp USA increased its Sana Biotechnology (SANA) stake by 67% in Q3 2026, buying an estimated $23.7K and bringing the position to 16,950 shares worth $49.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2174.
CIBC Bancorp USA first reported a position in SANA in Q3 2025 and has held it in 3 quarters since. The position peaked at $50.5K in Q3 2025. 173 funds tracked by Wall St. Rank hold SANA as of Q3 2026.
- CIBC Bancorp USA held 16,950 shares of Sana Biotechnology worth $49.4K as of Q3 2026.
- CIBC Bancorp USA bought 6,810 Sana Biotechnology shares in Q3 2026, an estimated $23.7K.
- Sana Biotechnology made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #2174 holding.
- CIBC Bancorp USA first reported a position in Sana Biotechnology in Q3 2025 and has held it in 3 quarters since.
- CIBC Bancorp USA's Sana Biotechnology position peaked at $50.5K in Q3 2025.
- 173 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.